Pyoderma gangrenosum: a review and update on new therapies
J Miller, BA Yentzer, A Clark, JL Jorizzo… - Journal of the American …, 2010 - Elsevier
Pyoderma gangrenosum is a rare and often painful skin disease that can be unpredictable
in its response to treatment. There is currently no gold standard of treatment or published …
in its response to treatment. There is currently no gold standard of treatment or published …
Treatment of pyoderma gangrenosum
RKP Chow, VC Ho - Journal of the American Academy of Dermatology, 1996 - Elsevier
Critical to the proper management of pyoderma gangrenosum are correct diagnosis,
identification and treatment of any underlying disorder, and the proper choice of topical and …
identification and treatment of any underlying disorder, and the proper choice of topical and …
Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment
A Alavi, LE French, MD Davis, A Brassard… - American journal of …, 2017 - Springer
Pyoderma gangrenosum (PG) is a rare inflammatory neutrophilic disorder with prototypical
clinical presentations. Its pathophysiology is complex and not fully explained. Recent …
clinical presentations. Its pathophysiology is complex and not fully explained. Recent …
Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: a prospective cohort study
KS Thomas, AD Ormerod, FE Craig, N Greenlaw… - Journal of the American …, 2016 - Elsevier
Background Pyoderma gangrenosum (PG) is an uncommon dermatosis with a limited
evidence base for treatment. Objective We sought to estimate the effectiveness of topical …
evidence base for treatment. Objective We sought to estimate the effectiveness of topical …
Management of pyoderma gangrenosum
FC Powell, M O'Kane - Dermatologic clinics, 2002 - derm.theclinics.com
Pyoderma gangrenosum (PG) can be defined as an inflammatory, reactive, non-infective,
non-neoplastic skin disease. It is one of the cutaneous disorders that may range from being …
non-neoplastic skin disease. It is one of the cutaneous disorders that may range from being …
Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients
J Reichrath, G Bens, A Bonowitz, W Tilgen - Journal of the American …, 2005 - Elsevier
Because the incidence of pyoderma gangrenosum (PG) is low, no prospective randomized
controlled trials and only a few studies with case numbers of more than 15 patients have …
controlled trials and only a few studies with case numbers of more than 15 patients have …
[引用][C] Therapeutic management of pyoderma gangrenosum
A Ehling, S Karrer, F Klebl, A Schäffler… - … : Official Journal of …, 2004 - Wiley Online Library
Pyoderma gangrenosum (PG) is a primarily noninfectious inflammatory skin disease
resulting in large ulcers that can spread rapidly showing undermined violaceous borders …
resulting in large ulcers that can spread rapidly showing undermined violaceous borders …
Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials
ACR Partridge, JW Bai, CF Rosen… - British journal of …, 2018 - academic.oup.com
Background Pyoderma gangrenosum (PG) is a neutrophilic dermatosis with substantial
morbidity. There is no consensus on gold‐standard treatments. Objectives To review the …
morbidity. There is no consensus on gold‐standard treatments. Objectives To review the …
Pyoderma gangrenosum: challenges and solutions
A Gameiro, N Pereira, JC Cardoso… - Clinical, cosmetic and …, 2015 - Taylor & Francis
Pyoderma gangrenosum (PG) is a rare disease, but commonly related to important
morbidity. PG was first assumed to be infectious, but is now considered an inflammatory …
morbidity. PG was first assumed to be infectious, but is now considered an inflammatory …
[PDF][PDF] Pyoderma gangrenosum: a systematic review
E Cozzani, G Gasparini, A Parodi - G Ital Dermatol Venereol, 2014 - researchgate.net
Pyoderma gangrenosum (PG) is a rare, chronic neutrophilic dermatosis of unknown
etiology. The world wide incidence is estimated to be around 3-10 cases per million …
etiology. The world wide incidence is estimated to be around 3-10 cases per million …
相关搜索
- pyoderma gangrenosum update on pathophysiology
- pyoderma gangrenosum systemic treatments
- pyoderma gangrenosum response of patients
- pyoderma gangrenosum topical therapy
- pyoderma gangrenosum challenges and solutions
- pyoderma gangrenosum therapeutic management
- pyoderma gangrenosum clinical outcomes
- pyoderma gangrenosum treatment recommendations
- pyoderma gangrenosum optimal treatment